Alcon
Alcon is the largest global eye care device company, operating two segments — Surgical (IOLs, phaco systems, surgical equipment) and Vision Care (contact lenses, ocular health products) — serving surgeons and patients in 140+ countries with 2025 net sales of $10.3 billion.
- Company typePublic
- Founded1945
- HeadquartersVernier, Switzerland
- Headcount5,001–10,000
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What Alcon does
Alcon is the largest eye care device company in the world, organized into two complementary business segments: Surgical and Vision Care. The Surgical segment covers cataract, vitreoretinal, and refractive surgery products, including intraocular lenses (PanOptix, Vivity, Clareon families with 175M+ cumulative implants), phacoemulsification platforms (Unity CS/VCS, CENTURION), vitreoretinal systems (CONSTELLATION), visualization systems (NGENUITY 3D), surgical planning tools (ORA SYSTEM, ARGOS Biometer), and glaucoma devices (Hydrus Microstent, BELKIN Vision DSLT). The Vision Care segment spans daily disposable, reusable, and color contact lens brands (DAILIES TOTAL1, TOTAL30, PRECISION1, PRECISION7, AIR OPTIX), ocular health products (Systane, Pataday, Tryptyr, EYSUVIS, ROCKLATAN, RHOPRESSA), and lens care solutions (OPTI-FREE, CLEAR CARE). The portfolio rests on proprietary technologies including Water Gradient contact lens chemistry, Opti-Balance IOL design, ACTIV-FLO moisture technology, and DropTainer dispensing, supported by $990M in 2025 R&D and a 74+ product pipeline.
Alcon operates across 60 countries with direct presence and serves patients in more than 140 countries through a hybrid B2B and consumer go-to-market. Surgical products move through dedicated field sales teams to hospitals, ambulatory surgical centers, and ophthalmologists, while Vision Care products reach consumers through eye care professionals, retail pharmacies, and direct-to-consumer e-commerce (including the MARLO app). Revenue is generated primarily through unit pricing on hardware sales (IOLs, contact lenses, surgical equipment, pharmaceuticals) rather than software or recurring subscriptions. 2025 net sales were $10.3 billion, with Q1 2026 sales of $2.685 billion (up 10% reported, 6% constant currency). The company is publicly traded on NYSE and SIX Swiss Exchange under ticker ALC, having spun off from Novartis in April 2019, and employs 25,000+ associates globally across 17 manufacturing sites.
Alcon firmographics
Firmographics- Name
- Alcon
- Legal name
- Alcon Inc.
- Website
- https://alcon.com
- Company type
- Public
- Founded year
- 1945
- Operating status
- Operating
- Headcount range
- 5,001–10,000 employees
- Short description
- Alcon is the largest global eye care device company, operating two segments — Surgical (IOLs, phaco systems, surgical equipment) and Vision Care (contact lenses, ocular health products) — serving surgeons and patients in 140+ countries with 2025 net sales of $10.3 billion.
- Ownership category
- akta.pro rank
Alcon industry classification
Industry- Product category
- Ophthalmic Devices and Vision Care Products
- NAICS
- Ophthalmic Goods Manufacturing (339115), Ophthalmic Goods Merchant Wholesalers (423460), Optical Goods Retailers (45613), Offices of Optometrists (62132)
- SIC
- Ophthalmic Goods (3851), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Cataract Surgery Systems & IOLs (Phaco Systems, IOLs, Intraoperative Aberrometry, Viscoelastics) (HLAHAJAH)
- akta.pro secondary industries
- Contact Lenses & Care Systems (Soft/RGP/Scleral Lenses; Cleaning/Disinfection Solutions) (HLAHAJAE), Optical Dispensing & Eyewear Devices (Frames, Lenses, Lens Edging/Finishing Equipment) (HLAHAJAD), Comprehensive Eye Exams & Vision Care (HLAKAKAA)
Keywords
Where Alcon is headquartered
LocationHeadquarters
- HQ city
- Vernier
- HQ country
- Switzerland
- HQ region
- Europe
Offices4 records
Markets served
Alcon business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- Surgical Products: Revenue from ophthalmic surgical products including implantables (IOLs), consumables, and surgical equipment. Net sales of $1.46 billion in Q1 2026.
- Vision Care Products: Revenue from contact lenses and ocular health products including dry eye treatments, lens care solutions, and allergy drops. Net sales of $1.225 billion in Q1 2026.
- Implantables: Intraocular lenses (IOLs) including Clareon, PanOptix, and Vivity families sold to surgical facilities and ophthalmologists
- Contact Lenses: Daily disposable, reusable, and color-enhancing contact lenses sold through eye care professionals and direct-to-consumer channels
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Contact lenses and solutions available through Eye Care Professionals |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels7 records
Alcon product offering
Product offeringCore offering
Alcon is a global eye care company that develops, manufactures, and sells ophthalmic surgical products (intraocular lenses, phacoemulsification systems, vitreoretinal equipment, glaucoma devices, refractive surgery lasers) and vision care products (contact lenses, dry eye treatments, allergy drops, lens care solutions). The portfolio spans two segments — Surgical and Vision Care — and serves eye care professionals (surgeons, ophthalmologists, optometrists) and patients/consumers in more than 140 countries.
Product overview
Alcon offers a comprehensive eye care portfolio organized into two core business segments: Surgical and Vision Care. The Surgical segment includes advanced technology intraocular lenses (ATIOLs) such as Clareon TruPlus, PanOptix Pro, PanOptix, and Vivity; surgical equipment platforms including Unity CS/VCS, CENTURION, and CONSTELLATION; visualization systems like NGENUITY 3D; glaucoma devices including Hydrus Microstent and Belkin Vision DSLT; refractive surgery technologies (WaveLight, LenSx); and the ORA SYSTEM and ARGOS Biometer for surgical planning. The Vision Care segment encompasses contact lenses (TOTAL30, PRECISION1, DAILIES TOTAL1, AIR OPTIX families), ocular health products (Systane, Pataday, Tryptyr, EYSUVIS), and lens care solutions (OPTI-FREE, CLEAR CARE). Supporting offerings include the Fidelis VR surgical simulator and MARLO patient app. The portfolio serves patients across cataracts, glaucoma, retinal diseases, refractive errors, dry eye, and contact lens categories.
Differentiator
Problem solved
Functional benefit
Brands
- CLAREON: Family of intraocular lenses (IOLs) including monofocal, toric, and presbyopia-correcting options.
- SYSTANE
- TOTAL30
- PRECISION1
- PRECISION7
- DAILIES TOTAL1
- AIR OPTIX
- OPTIFREE
- Pataday
- Hydrus Microstent
- Unity
- PanOptix
- Vivity
- CENTURION
- CONSTELLATION
- NGENUITY
- WaveLight
- Tryptyr
Products and services
- Clareon TruPlus IOL Enhanced design monofocal and toric intraocular lens (IOL) featuring proprietary Opti-Balance Technology to increase depth of focus while maintaining high-quality distance vision, intended for ophthalmic surgeons performing cataract surgery.
- Unity CS Cataract System Next-generation standalone cataract surgical platform featuring novel phacoemulsification technology delivering up to 2x faster nucleus removal with 40% less energy into the eye, with a first-of-its-kind phaco handpiece that estimates temperature at the incision site, for cataract surgeons.
- Unity VCS Cataract Platform Cataract surgical platform featuring phacoemulsification technology for improved surgical outcomes, supporting cataract surgery workflow.
- PanOptix Trifocal IOL First and only trifocal intraocular lens in the U.S., the world's most implanted trifocal IOL with over 4 million implants, designed for cataract surgeons treating presbyopia during cataract surgery.
- PanOptix Pro IOL Presbyopia-correcting trifocal intraocular lens, next generation of the PanOptix family for cataract surgery.
- Vivity IOL Extended depth of focus IOL, the leading EDoF lens with over 2 million implants, offering wavefront-shaping presbyopia correction for cataract surgery patients.
- AcrySof IQ IOL First intraocular lens with material developed specifically for IOL implantation, FDA-approved in 1994, used by ophthalmologists for cataract surgery.
- CENTURION Vision System Alcon's most advanced phacoemulsification technology platform for cataract surgery, launched in 2013.
- CONSTELLATION Vision System Vitreoretinal surgery system used by retinal surgeons for retinal procedures.
- NGENUITY 3D Visualization System
Quantifiable outcome
- 2x faster nucleus removal with 40% less energy vs OZIL Torsional phaco (Unity CS)
- +3 more outcomes
Companies that use Alcon
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles2 records
Alcon technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
Alcon partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered major and minor.
- Orbis InternationalmajorLong-standing partnership spanning over 40 years supporting Orbis Flying Eye Hospital programs. Alcon provides product donations, equipment, and expertise to expand access to eye care in underserved regions including Peru, Senegal, and Mongolia. The partnership includes a five-year national collaboration with the Ministry of Health.
- PerZeption Inc.minorCollaboration to present new data validating AIM+ CSF modeling technology at ARVO annual meeting in May 2026. The technology enables rapid, repeatable contrast vision assessment for vision correction assessment.
- Toronto Blue JaysminorSystane partnership making it the official eye drop of the team, raising awareness about dry eye among Canadians with stadium activations and digital initiatives.
- Parrot AnalyticsminorStrategic partnership for Alcon Media Group integrating global cross-platform entertainment analytics and content valuation for IP investment strategy and talent planning.
- Glaucoma Research FoundationminorPartnership to expand access to glaucoma education resources in Spanish in the United States, serving Spanish-speaking and visually impaired patients at higher risk for glaucoma.
- Laurel Surgical FoundationminorPartnership supporting volunteer surgical missions including Mongolia trip where 127 cataract surgeries were performed. Alcon Canada associates volunteered alongside the surgical team.
- Plastic BankminorPartnership since 2022 to build recycling ecosystems in underdeveloped communities and offset plastic used in select Alcon Surgical and Vision Care products.
Scale indicators15 records
Recent moves7 records
Expansion highlights6 records
Alcon competitors and assessment
Company assessmentDirect peers
- Carl Zeiss Meditec: Zeiss Meditec manufactures ophthalmic surgical microscopes, IOLs (CT LUCIA, AT ELANA), and surgical equipment — competing directly with Alcon's CENTURION/Unity platforms and IOL franchises in surgical suites.
- CooperVision: CooperVision is a global contact lens specialist with daily, two-week, and monthly silicone hydrogel lenses (MyDay, clariti, Biofinity), competing head-to-head with Alcon's DAILIES TOTAL1, PRECISION, and AIR OPTIX families.
- Bausch + Lomb: Bausch + Lomb is a comprehensive eye care company with overlapping Surgical and Vision Care portfolios including IOLs, contact lenses (Biotrue), ophthalmic pharmaceuticals, and surgical equipment — making it Alcon's closest end-to-end competitor across both segments.
- Glaukos Corporation: Glaukos pioneered MIGS devices (iStent) for glaucoma and competes directly with Alcon's Hydrus Microstent in the minimally invasive glaucoma surgery market — overlapping Surgical segment customers and clinical use cases.
- Sight Sciences: Sight Sciences develops MIGS devices (OMNI) and dry eye products (TearCare) — overlapping with Alcon's Hydrus Microstent glaucoma franchise and Systane/Tryptyr dry eye portfolio, and a direct IP litigant against Alcon.
- HOYA Corporation: HOYA Surgical Optics manufactures IOLs (Vivinex, iSert) and competes with Alcon in the cataract surgery IOL market, while HOYA Vision Care produces eyeglass lenses — overlapping both of Alcon's primary segments.
- Johnson & Johnson Vision: J&J Vision (Acuvue, TECNIS IOLs, iDesign LASIK) competes directly with Alcon in daily disposable contact lenses, premium IOLs, and refractive surgery — overlapping core Vision Care and Surgical categories.
- STAAR Surgical: STAAR Surgical makes Implantable Collamer Lenses (ICL) for refractive vision correction and competed as an acquisition target for Alcon's refractive expansion; comparable as a fellow ophthalmic implantable lens specialist.
- LENSAR: LENSAR makes femtosecond laser cataract surgery systems (ALLY) and was Alcon's terminated acquisition target — directly competing in the same femto cataract surgery category where the FTC blocked Alcon's M&A.
Broad incumbents
- Topcon Corporation: Topcon is a broader ophthalmic diagnostic and imaging equipment maker (OCT, fundus cameras, refractive systems) overlapping with Alcon's surgical visualization and diagnostic-adjacent offerings within the same surgical suites.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights6 records
Customer concentration
Alcon social profiles
Digital presenceAlcon compliance and trust
Trust signalCompliance39 records
Alcon financial estimates
Financial estimateRevenue estimate
Valuation estimate
Alcon leadership team
Management profileNumber of profiles
Profiles19 records
Alcon subsidiaries and ownership
Company hierarchySubsidiaries9 records
Alcon funding detail
Funding detailFunding overview
Funding rounds2 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Alcon M&A and investment
M&A and investmentM&A17 records
Investments3 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Alcon
What does Alcon do?
Alcon is a global eye care company that develops, manufactures, and sells ophthalmic surgical products (intraocular lenses, phacoemulsification systems, vitreoretinal equipment, glaucoma devices, refractive surgery lasers) and vision care products (contact lenses, dry eye treatments, allergy drops, lens care solutions). The portfolio spans two segments — Surgical and Vision Care — and serves eye care professionals (surgeons, ophthalmologists, optometrists) and patients/consumers in more than 140 countries.
Is Alcon a public or private company?
Alcon is a public company. It is classified as public and is currently operating.
When was Alcon founded?
Alcon was founded in 1945. It employs 5,001 to 10,000 people.
Where is Alcon based?
Alcon is headquartered in Vernier, Switzerland, in the Europe region.
How does Alcon make money?
Four revenue lines are on record. Surgical Products are the primary driver. The others are vision Care Products, implantables and contact Lenses.
Who are Alcon's main competitors?
Direct peers on record are Carl Zeiss Meditec, CooperVision, Bausch + Lomb, Glaukos Corporation, Sight Sciences, HOYA Corporation, Johnson & Johnson Vision, STAAR Surgical and LENSAR. Topcon Corporation is listed as a broad incumbent.
Does Alcon have an API?
No public API is recorded for Alcon.
What industry is Alcon in?
Alcon's product category is Ophthalmic Devices and Vision Care Products. Its primary akta.pro industry code is HLAHAJAH, Cataract Surgery Systems & IOLs (Phaco Systems, IOLs, Intraoperative Aberrometry, Viscoelastics), with a secondary code of HLAHAJAE, Contact Lenses & Care Systems (Soft/RGP/Scleral Lenses; Cleaning/Disinfection Solutions). Its NAICS code is 339115 and its SIC code is 3851.